Popular Articles

Access Pharmaceuticals Announces Publication Of Thiarabine Combination Data
ACCESS PHARMACEUTICALS, INC. (OTC Bulletin Board: ACCP), announced that new Thiarabine preclinical efficacy data will shortly be published demonstrating that thiarabine combined with clofarabine provides much greater antitumor activity than achieved by either agent alone. In one colorectal cancer model, 66% of mice were cured of their tumors. The publication which will appear in the journal "Cancer Chemotherapy and Pharmacology," was based on work conducted by Access" collaborators at the Southern Research Institute. The paper is entitled "Enhancement of the in vivo antitumor activity of clofarabine by 1-beta-D-[4-thio-arabinofuranosyl]-cytosine" (thiarabine).

US Navy Culture And Workplace Leads To Heavy Drinking
The nature of the U.S. Navy workplace leads to higher heavy drinking for sailors than for civilians, according to an article in the May issue of the Journal of Mixed Methods Research published by SAGE.
News of the day
SYNTAX Substudy Shows Positive Outcomes For Left Main Patients Treated With TAXUS(R) Express2(R) Stent System
Boston Scientific Corporation (NYSE: BSX) announced positive outcomes from a substudy of patients with left main coronary disease who were treated with the TAXUS(R) Express2(R) Paclitaxel-Eluting Coronary Stent System. SYNTAX-LE MANS is a substudy of the landmark SYNTAX trial, the first randomized, controlled clinical trial to compare percutaneous coronary intervention (PCI) using the TAXUS Stent to coronary artery bypass graft (CABG) surgery in patients with left main disease and/or significant narrowing of all three coronary arteries (three-vessel disease). The substudy data were presented by A. Pieter Kappetein, M.D., Ph.D., at the annual EuroPCR Scientific Program in Barcelona.
Endocrinology

UNAIDS Welcomes Continued Commitment Of Francophone Parliamentarians To The AIDS Response

The Assembly of parliamentarians of Francophone countries have adopted a resolution reaffirming their commitment to the AIDS response. The resolution, which was adopted during their annual assembly which was held from 3 to 6 July 2009 in Paris, gave a strong message that Francophone parliamentarians are continuing to put AIDS high on the agenda and push the response forward in their countries and beyond. "I am encouraged to see this level of leadership from Francophone countries to the AIDS response," said Michel Sidibç©, Executive Director of UNAIDS. "Francophone countries in Africa, South East Asia and the Caribbean bear a significant burden of the global AIDS epidemic and a strong response is needed to break the trajectory of the epidemic and start building a better future for people affected by HIV." The resolution outlines several recommendations including; strengthening HIV prevention efforts, particularly among groups at higher risk of HIV infection; rejecting punitive laws including the criminalisation of HIV transmission and laws which prevent marginalised groups from accessing health services; free access to antiretroviral drugs for all in need; full use of the TRIPS agreement on compulsory licensing; and ensuring that sufficient funds are made available to developing African and Asian nations to reinforce public health systems. The resolution also highlights the need to coordinate efforts with organisations such as UNAIDS Secretariat and Cosponsors and the European parliament. During the plenary session which took place prior to the signing of the resolution, Abdou Diouf, General Secretary of the International organisation of Francophonie and former President of Senegal, underlined the important role the parliamentarians have to play in removing the discriminative and punitive laws which are so detrimental to the AIDS response. He also reaffirmed his personal engagement in the AIDS response and praised the new leadership of UNAIDS for reinvigorating momentum around the AIDS response. The resolution highlights several areas of concern including the large numbers of people living with HIV in francophone countries, the limited access to and high cost of antiretroviral treatment, and the need to protect human rights of vulnerable people and groups at higher risk of HIV infection. The resolution also warns that without an effective response to poverty reduction the response to HIV would be weak and would not contribute significantly to sustainable development efforts. UNAIDS


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):